[Myotoxicity and rhabdomyolisis due to statins].
作者信息
Cohen L H
出版信息
Ned Tijdschr Geneeskd. 2002 Mar 2;146(9):440-1; author reply 441.
PMID:11901950
Abstract
摘要
相似文献
1
[Myotoxicity and rhabdomyolisis due to statins].
Ned Tijdschr Geneeskd. 2002 Mar 2;146(9):440-1; author reply 441.
2
[Myotoxicity and rhabdomyolisis due to statins].他汀类药物引起的肌毒性和横纹肌溶解症
Ned Tijdschr Geneeskd. 2001 Dec 8;145(49):2371-6.
3
Muscular adverse effects of statins.
Prescrire Int. 2003 Feb;12(63):21.
4
Statins and myotoxicity.
Trends Pharmacol Sci. 2003 Mar;24(3):113-4. doi: 10.1016/S0165-6147(03)00022-1.
5
Localized rhabdomyolysis after exertion in a cardiac transplant recipient on statin therapy.接受他汀类药物治疗的心脏移植受者在运动后发生局部横纹肌溶解症。
J Heart Lung Transplant. 2006 Mar;25(3):356-7. doi: 10.1016/j.healun.2005.09.009. Epub 2006 Jan 6.
6
[Myopathy with rhabdomyolysis as an adverse effect of simultaneous treatment with cerivastatin and gemfibrozil].[以横纹肌溶解为不良反应的肌病——同时使用西立伐他汀和吉非贝齐治疗所致]
Lijec Vjesn. 2002 Mar-Apr;124(3-4):73-6.
7
Rhabdomyolysis and cerivastatin: was it a problem of dose?横纹肌溶解症与西立伐他汀：这是剂量问题吗？
CMAJ. 2002 Oct 1;167(7):737.
8
On call. Statins and muscle damage.
Harv Mens Health Watch. 2007 Aug;12(1):8.
9
Estimating the extent of reporting to FDA: a case study of statin-associated rhabdomyolysis.评估向美国食品药品监督管理局（FDA）报告的范围：以他汀类药物相关横纹肌溶解症为例的研究
Pharmacoepidemiol Drug Saf. 2008 Mar;17(3):229-39. doi: 10.1002/pds.1535.
10
[Cerivastatin and acute kidney failure caused by rhabdomyolysis].[西立伐他汀与横纹肌溶解所致急性肾衰竭]
Nefrologia. 2001 Sep-Oct;21(5):509.
Zotero 插件